Clinical Trial Update: Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on buprenorphine/naloxone dosing and its effects on stress reactivity and opioid abstinence in heroin dependence and opioid use disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heroin Dependence
• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: Wayne State University | Conditions: Heroin Dependence, Opioid Use Disorder | Phase 1, Phase 2 | Status: COMPLETED